Skip to main content
Premium Trial:

Request an Annual Quote

Agendia Receives CE Mark for CupPrint

NEW YORK (GenomeWeb News) - Agendia's CupPrint microarray service has acquired Medical Device registration at the Dutch Healthcare Inspectorate, the company said today.

 
Agendia received CE registration for MammaPrint in 2005.
 
CupPrint is a test for cancer of unknown primary patients.
 
"With the CE registration of both its products and the ISO 17025 accreditation of its laboratory services, Agendia ... [can] market its products and ... provide a legal basis for its use in clinical practice," Laura van 't Veer, COO of Agendia, said in a statement.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.